Review paper compares two leading pancreatic cancer drugs
An in-depth analysis of two common treatments for advanced pancreatic cancer from The University of Toledo has found the combination chemotherapy drug Folfirinox is more likely to promote progression-free survival—a notable ...
Feb 8, 2024
0
2